Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crouch, B. I.
Right arrow Articles by Moltz, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crouch, B. I.
Right arrow Articles by Moltz, E.
American Journal of Health-System Pharmacy, Vol. 66, Issue 14, 1292-1296
Copyright © 2009. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00


Clinical Report

Tenfold therapeutic dosing errors in young children reported to U.S. poison control centers

Barbara Insley Crouch, E. Martin Caravati and Ed Moltz

BARBARA INSLEY CROUCH, PHARMD., M.S.P.H., is Director, Utah Poison Control Center (UPCC), Salt Lake City; and Professor (Clinical) and Vice-Chair, Department of Pharmacotherapy, College of Pharmacy, University of Utah (UU), Salt Lake City. E. MARTIN CARAVATI, M.D., M.P.H., is Professor, Division of Emergency Medicine, Department of Surgery, and Medical Director, UPCC. ED MOLTZ, B.S.N., CSPI, is Certified Specialist in Poison Information, UPCC, Department of Pharmacotherapy, College of Pharmacy, UU.

Address correspondence to Dr. Crouch at the Department of Pharmacotherapy, College of Pharmacy, University of Utah, 585 Komas Drive, Suite 200, Salt Lake City, UT 84108 (barbara.crouch{at}hsc.utah.edu).


Purpose. Tenfold dosing medication errors reported to U.S. poison control centers in children younger than six years of age were evaluated.

Methods. A retrospective review of all exposures in children younger than six years of age reported to the American Association of Poison Control Centers’ data collection system during 2000–04 was conducted. Cases were selected for inclusion if the exposure was an unintentional therapeutic error and if 10-fold dosing error was coded as one of the therapeutic-error scenarios. The specific substance or drug category, patient age and sex, site of exposure, clinical effects, disposition, and outcome were evaluated

Results. A total of 3894 10-fold dosing errors involving a single substance in children younger than six years of age were reported over a five-year period. The site of exposure was most commonly a residence (n = 3609, 92.7%), followed by a health care facility (n = 223, 5.7%) and a school (n = 32, 0.8%). More than half of the exposures occurred in children 12 months of age or younger. When stratified by age, histamine H2- receptor antagonists and metoclopramide were the most common medications involved in exposures in children 12 months of age and younger. Cough and cold preparations and antibiotics were the most commonly involved medications in therapeutic errors in children over age 12 months.

Conclusion. The most common substances involved in 10-fold medication errors reported to U.S. poison control centers were histamine H2-receptor antagonists and metoclopramide. Most exposures occurred in the home and involved children 12 months of age or younger.

Index terms: Data collection; Dosage; Errors, medication; Gastrointestinal drugs; Metoclopramide; Pediatrics; Poison control centers; Poisoning

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Health-System Pharmacists.
Advertisement